A New View For Pharma Product Liability Litigation
But tort reform over the last decade stemmed the tide of litigation, and two judicial decisions in the past four months may have forever changed the landscape for pharmaceutical products liability in Texas.
In Lofton, the U.S. Court of Appeals for the Fifth Circuit expanded the circumstances under which warnings for U.S. Food and Drug Administration-approved prescription drugs...
Already a subscriber? Click here to login